or Try an Advanced Search...

    Technical Analysis for IGMS - IGM Biosciences, Inc.

    Grade Last Price % Change Price Change
    C 13.89 2.21% 0.30
    IGMS closed up 2.21 percent on Thursday, October 10, 2024, on 48 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical IGMS trend table...
    Date Alert Name Type % Chg
    1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Calm After Storm Range Contraction 2.21%
    NR7 Range Contraction 2.21%
    NR7-2 Range Contraction 2.21%
    Wide Bands Range Expansion 2.21%
    Calm After Storm Range Contraction -4.54%
    Older End-of-Day Signals for IGMS ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 18 hours ago
    60 Minute Opening Range Breakdown about 21 hours ago
    Down 3% about 21 hours ago
    Up 3% about 22 hours ago
    Up 2% about 22 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    IGMS Chart by TradingView
    Basic chart:

    Profile

    Headquartered in Mountain View, California, IGM Biosciences is a biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of cancer patients. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Immunology Antibodies Treatment Of Cancer Glycoproteins Biochemistry Protein Engineering Immunoglobulin M

    Is IGMS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 1 IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO
    Oct 1 IGM Biosciences downgraded to Hold, stock falls
    Oct 1 These Stocks Are Moving the Most Today: Boeing, Super Micro, HP Inc., CVS, Ford, NIO, IGM Biosciences, and More
    Oct 1 Top 1% Biotech, IGM Biosciences, Plummets On Scrapped Drug, C-Suite Makeover
    Oct 1 IGM Biosciences Stock Drops Sharply on ‘Pipeline Transformation’ to Autoimmune Diseases
    Oct 1 IGM lays off staff in autoimmune pivot; Metsera ramps up obesity drug supply
    Sep 30 IGM Biosciences to minimize spending on oncology candidates, appoints new CEO
    Sep 30 IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity
    Sep 27 While shareholders of IGM Biosciences (NASDAQ:IGMS) are in the black over 1 year, those who bought a week ago aren't so fortunate
    Sep 18 IGM Biosciences: Waiting For Godot
    See more IGMS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 22.5
    52 Week Low 3.81
    Average Volume 311,202
    200-Day Moving Average 10.48
    50-Day Moving Average 12.08
    20-Day Moving Average 15.48
    10-Day Moving Average 14.85
    Average True Range 1.86
    RSI (14) 49.24
    ADX 34.25
    +DI 24.43
    -DI 21.73
    Chandelier Exit (Long, 3 ATRs) 16.92
    Chandelier Exit (Short, 3 ATRs) 16.54
    Upper Bollinger Bands 18.28
    Lower Bollinger Band 12.68
    Percent B (%b) 0.22
    BandWidth 36.18
    MACD Line 0.52
    MACD Signal Line 0.97
    MACD Histogram -0.4528
    Fundamentals Value
    Market Cap 456.89 Million
    Num Shares 32.9 Million
    EPS -4.90
    Price-to-Earnings (P/E) Ratio -2.83
    Price-to-Sales 408.54
    Price-to-Book 3.34
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 15.51
    Resistance 3 (R3) 15.40 14.75 15.24
    Resistance 2 (R2) 14.75 14.33 14.80 15.15
    Resistance 1 (R1) 14.32 14.08 14.53 14.43 15.06
    Pivot Point 13.66 13.66 13.77 13.72 13.66
    Support 1 (S1) 13.24 13.25 13.45 13.35 12.72
    Support 2 (S2) 12.58 13.00 12.64 12.63
    Support 3 (S3) 12.15 12.58 12.54
    Support 4 (S4) 12.27